Join us on the NextGenVC Podcast as we dive into the inspiring journey of Dr. Tia Lyles-Williams, a trailblazer in the biotech industry. Discover how mentorship shaped her path, the challenges she overcame, and her vision for inclusive biotech innovation through her accelerator, HiveBio. Dr. Tia shares insights on building a community-driven biotech ecosystem and the importance of perseverance in the face of obstacles. Tune in for an engaging conversation that highlights the dynamic world of venture capital and biotech in Philadelphia.

Hosts Mike Hostetler and Jen Fang are joined by Jon Chee, CEO of Excedr and host of The Biotech Startups Podcast. Jon shares insights from his work with early-stage life science companies, trends he's observing in biotech, and what he’s learned from interviewing founders and industry leaders on his own podcast. He also reflects on the importance of company culture, capital structure, and resilience in building successful biotech ventures. Tune in to hear how Jon is helping founders navigate startup challenges, scale smarter, and stay focused on science.

In this episode, hosts Jen Fang and Mike Hostetler welcome guest Ran Geng, a Principal on the Private Equity Team at OrbiMed. The discussion covers the unique opportunities and challenges in the Chinese market, including government policies, the rise of tech startups, and more. They also explore the influence of China's rapid technological advancements, current investment trends, and strategies investors can adopt to succeed in this quickly evolving landscape.

In this episode of the NextGenVC podcast, hosts Jen Fang and Mike Hostetler are joined by Chris Garabedian, founder of Xontogeny and biopharma veteran, to discuss the transformative impact of early-stage biotech investment. Chris shares his journey from biotech corporate leadership to venture capital, emphasizing the importance of thoughtful drug development and the value of nurturing early-stage companies. He explains the inception of Xontogeny, its collaboration with Perceptive Advisors, and the unique venture incubation model they follow. Chris also highlights the essential qualities for success in biotech investing and offers insights for budding entrepreneurs and potential VCs alike.

On this episode of the NextGen VC Podcast, we’re joined by Dr. Josep Bassaganya-Riera, the president and CEO of NImmune Biopharma and founder of The NIMML Institute, a nonprofit research organization. A scientist turned entrepreneur, Josep shares his journey from academia to launching multiple biotech ventures, including Lando Biopharma (acquired by AbbVie). He reflects on the pivotal moments that led him to leave the university world and build companies at the intersection of science and innovation. We dive into the early stages of company formation, his experiences working with investors like Chris Garabedian and Perceptive Advisors, and why maintaining control over company direction and governance is critical—especially for repeat founders. Josep also shares insights on the future of immunotherapy and the promise of precision medicine in treating autoimmune and inflammatory diseases. Don’t miss this fascinating conversation!

In this episode of the Next Gen VC podcast, hosts Mike Hostetler and Jen Fang sit down with Felix Breyer from J.P. Morgan Life Sciences Private Capital. Felix, with a background as a molecular and cellular biologist, dives deep into the critical role of private capital in life sciences and biotech. He shares his journey from academia to venture capital, emphasizes the importance of mentorship, and provides an insider's perspective on the evolving landscape of biotech investing. Tune in to explore key trends, challenges, and opportunities in the biotech sector, and gain valuable insights for aspiring venture capitalists. Sponsored by Wilson Sonsini and Launch Bio.

In this episode of the NextGenVC podcast, Mike Hostetler and Jen Fang sit down with Enrique Lin Shiao, a venture investor and fellow podcaster, to discuss his fascinating journey from earning a PhD at the University of Pennsylvania to becoming a key player in venture philanthropy, especially in the realm of cystic fibrosis research and treatment. Enrique shares his experiences with his podcast ‘Caminos en Ciencia,’ his insights into the development and challenges of genetic medicine, and the impactful work being done at the Cystic Fibrosis Foundation. Tune in to explore how his diverse background and unique perspective drive meaningful investments that push the boundaries of what’s possible in biotech and venture philanthropy.

00:58 Enrique Lin Shiao's Podcasting Journey

03:50 Navigating Uncertainty in Science and VC0

4:52 Enrique's Academic and Professional Path

10:31 Venture Philanthropy Explained

11:58 Cystic Fibrosis Foundation's Impact

24:20 Future of Venture Philanthropy

27:55 Global Perspectives and Diversity in VC

37:58 Advice for Aspiring Venture Capitalists

43:00 Conclusion and Final Thoughts

In this episode of the NextGen VC podcast, hosts Mike Hostetler and Jen sit down with Danjuma Quarless from AbbVie Ventures to delve into the world of corporate venture capital. Danjuma shares insights on how corporate VCs like AbbVie differ from traditional VCs, particularly in the biotech and pharmaceutical industries. Listeners will learn about the strategic focus of AbbVie Ventures, the importance of scientific and competitive differentiation in securing investment, and the fluid communication within AbbVie's ecosystem. Danjuma also shares his personal journey from a research scientist to a venture capitalist, offering valuable advice for those looking to break into the venture capital space. The podcast also touches on the current trends in biotech, the challenges and opportunities in various regional ecosystems, and the importance of promoting diversity within the venture capital industry. Tune in to hear about the latest innovations in biotech, the differences in investment approaches between various regions, and how AbbVie Ventures aims to build communities and support underrepresented groups in the industry.